<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33252665</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients.</ArticleTitle><Pagination><StartPage>e4058</StartPage><EndPage>e4063</EndPage><MedlinePgn>e4058-e4063</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ciaa1792</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciaa1792</ELocationID><Abstract><AbstractText Label="BACKGROUND">Little is known about long-term recovery from coronavirus disease 2019 (COVID-19) disease, especially in nonhospitalized individuals. In this longitudinal study we present symptoms registered during the acute phase as well as long COVID (ie, long-lasting COVID-19 symptoms) in patients from the Faroe Islands.</AbstractText><AbstractText Label="METHODS">All consecutive patients with confirmed reverse transcription-polymerase chain reaction testing from April to June 2020 were invited to participate in this study for the assessment of long COVID. Demographic and clinical characteristics and self-reported acute and persistent symptoms were assessed using a standardized detailed questionnaire administered at enrollment and at repeated phone interviews in the period 22 April to 16 August.</AbstractText><AbstractText Label="RESULTS">Of the 180 participants (96.3% of the 187 eligible COVID-19 patients), 53.1% reported persistence of at least 1 symptom after a mean of 125 days after symptoms onset, 33.0% reported 1 or 2 symptoms, and 20.1% reported 3 or more symptoms. At the last follow-up, 46.9% were asymptomatic compared with 4.4% during the acute phase. The most prevalent persistent symptoms were fatigue, loss of smell and taste, and arthralgias.</AbstractText><AbstractText Label="CONCLUSIONS">Our results show that it might take months for symptoms to resolve, even among nonhospitalized persons with mild illness course in the acute phase. Continued monitoring for long COVID is needed.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Maria Skaalum</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-9404-8440</Identifier><AffiliationInfo><Affiliation>Centre of Health Sciences, Faculty of Health Sciences, University of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Occupational Medicine and Public Health, The Faroese Hospital System, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kristiansen</LastName><ForeName>Marnar Fr&#xed;&#xf0;heim</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Centre of Health Sciences, Faculty of Health Sciences, University of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Department, National Hospital of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 Task Force, Ministry of Health, Faroe Islands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanusson</LastName><ForeName>Katrin Dahl</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine and Public Health, The Faroese Hospital System, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danielsen</LastName><ForeName>Marjun Eivindard&#xf3;ttir</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine and Public Health, The Faroese Hospital System, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 Task Force, Ministry of Health, Faroe Islands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1; Steig</LastName><ForeName>Bjarni</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Department, National Hospital of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 Task Force, Ministry of Health, Faroe Islands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaini</LastName><ForeName>Shahin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Department, National Hospital of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Str&#xf8;m</LastName><ForeName>Marin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre of Health Sciences, Faculty of Health Sciences, University of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weihe</LastName><ForeName>P&#xe1;l</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre of Health Sciences, Faculty of Health Sciences, University of the Faroe Islands, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Occupational Medicine and Public Health, The Faroese Hospital System, T&#xf3;rshavn, Faroe Islands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Cooperation's p/f Kr&#xfa;nborg and Bortart&#xfa;n</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Faroe Islands</Keyword><Keyword MajorTopicYN="N">longitudinal study</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>30</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33252665</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pii">6012625</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>